Designed as an adjunct to care for MDD and GAD, Ensemble must be prescribed by a clinician to treat these disorders.
The two companies will work together to test reducing clinical depression and anxiety in prone population.
Under the program, Happify will team with academic researchers to conduct clinical trials on interventions related to positive psychology and neuroscience.
The two parties will deliver solutions for family caregivers who serve more than 130 million people suffering from chronic conditions in the United States.
The service uses both subjective and existing objective evaluations, based on the science of positive psychology, neuroscience, and behavioral health.